Santen Pharmaceutical Statistics
Total Valuation
SNPHY has a market cap or net worth of 3.46 billion. The enterprise value is 2.82 billion.
| Market Cap | 3.46B |
| Enterprise Value | 2.82B |
Important Dates
The last earnings date was Tuesday, May 13, 2025.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -5.01% |
| Shares Change (QoQ) | -0.75% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 329.77M |
Valuation Ratios
The trailing PE ratio is 14.28.
| PE Ratio | 14.28 |
| Forward PE | n/a |
| PS Ratio | 1.73 |
| PB Ratio | 1.82 |
| P/TBV Ratio | 2.46 |
| P/FCF Ratio | 9.54 |
| P/OCF Ratio | 8.50 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.43, with an EV/FCF ratio of 7.77.
| EV / Earnings | 11.63 |
| EV / Sales | 1.37 |
| EV / EBITDA | 6.43 |
| EV / EBIT | 8.93 |
| EV / FCF | 7.77 |
Financial Position
The company has a current ratio of 2.58
| Current Ratio | 2.58 |
| Quick Ratio | 1.90 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 17.26 |
Financial Efficiency
Return on equity (ROE) is 12.14% and return on invested capital (ROIC) is 9.37%.
| Return on Equity (ROE) | 12.14% |
| Return on Assets (ROA) | 6.94% |
| Return on Invested Capital (ROIC) | 9.37% |
| Return on Capital Employed (ROCE) | 14.54% |
| Revenue Per Employee | 535,094 |
| Profits Per Employee | 64,667 |
| Employee Count | 3,744 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 2.72 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.57% in the last 52 weeks. The beta is 0.20, so SNPHY's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | -7.57% |
| 50-Day Moving Average | 9.74 |
| 200-Day Moving Average | 10.76 |
| Relative Strength Index (RSI) | 50.49 |
| Average Volume (20 Days) | 7,776 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SNPHY had revenue of 2.00 billion and earned 242.11 million in profits. Earnings per share was 0.69.
| Revenue | 2.00B |
| Gross Profit | 1.14B |
| Operating Income | 313.06M |
| Pretax Income | 317.07M |
| Net Income | 242.11M |
| EBITDA | 432.91M |
| EBIT | 313.06M |
| Earnings Per Share (EPS) | 0.69 |
Balance Sheet
The company has 621.02 million in cash and n/a in debt, giving a net cash position of 621.02 million.
| Cash & Cash Equivalents | 621.02M |
| Total Debt | n/a |
| Net Cash | 621.02M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.90B |
| Book Value Per Share | 5.60 |
| Working Capital | 917.96M |
Cash Flow
In the last 12 months, operating cash flow was 406.87 million and capital expenditures -44.49 million, giving a free cash flow of 362.38 million.
| Operating Cash Flow | 406.87M |
| Capital Expenditures | -44.49M |
| Free Cash Flow | 362.38M |
| FCF Per Share | n/a |
Margins
Gross margin is 57.01%, with operating and profit margins of 15.63% and 12.09%.
| Gross Margin | 57.01% |
| Operating Margin | 15.63% |
| Pretax Margin | 15.83% |
| Profit Margin | 12.09% |
| EBITDA Margin | 21.61% |
| EBIT Margin | 15.63% |
| FCF Margin | 18.09% |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 2.43%.
| Dividend Per Share | 0.25 |
| Dividend Yield | 2.43% |
| Dividend Growth (YoY) | 11.90% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 33.40% |
| Buyback Yield | 5.01% |
| Shareholder Yield | 7.45% |
| Earnings Yield | 7.00% |
| FCF Yield | 10.48% |
Stock Splits
The last stock split was on April 2, 2015. It was a forward split with a ratio of 2.5.
| Last Split Date | Apr 2, 2015 |
| Split Type | Forward |
| Split Ratio | 2.5 |
Scores
SNPHY has an Altman Z-Score of 5.06.
| Altman Z-Score | 5.06 |
| Piotroski F-Score | n/a |